DigestRedComo funciona
Red
/
Empresas
Re
No verificado

ReAlta Life Sciences, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

15 Comunicados de prensa

Ver todos los comunicados de prensa
06/11/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
ReAlta Life Sciences to Present RLS-0071 (pegtarazimod) Clinical Data at 2025 American Society of Hematology Annual Meeting
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
21/08/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
ReAlta Life Sciences Receives EMA Orphan Drug Designation for RLS-0071 (pegtarazimod) for the Treatment of Graft-Versus-Host Disease
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
28/07/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
22/07/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
ReAlta Life Sciences Publishes Data Demonstrating RLS-0071 (pegtarazimod) Reduces Brain Inflammation in Preclinical Hypoxic Ischemic Encephalopathy Model
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
19/05/2025
Eventos
Ferias y Congresos
Industria
Ciencia
VIH, SIDA y enfermedades autoinmunes
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
ReAlta Life Sciences Announces New Inflammatory Biomarker Data from Acute Exacerbations of Chronic Obstructive Pulmonary Disease Program at American Thoracic Society 2025 International Conference
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
25/04/2025
Eventos
Ferias y Congresos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic Ischemic Encephalopathy Program at Pediatric Academic Societies 2025 Meeting
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
08/04/2025
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
ReAlta Life Sciences to Present New Clinical Data from Hypoxic Ischemic Encephalopathy Program at Pediatric Academic Societies 2025 Meeting
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
01/04/2025
Mercado laboral
Biotecnología
Salud
Ciencia
Farmacéutica
ReAlta Life Sciences Announces Appointment of Distinguished Immunologist, Laurie Glimcher, M.D., to Board of Directors
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
25/02/2025
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Salud
Mercado laboral
ReAlta Life Sciences Announces Appointment of Biotechnology Leader Andrew Miller, Ph.D., to Board of Directors
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0
08/12/2024
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
ReAlta Life Sciences Announces Positive Preclinical Data for RLS-0071 (pegtarazimod) in Acute Graft-Versus-Host Disease (aGVHD) at American Society of Hematology Annual Meeting
Fuente
ReAlta Life Sciences, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0